Alamar Biosciences, Inc.
ALMRNasdaqHealthcare · Laboratory Analytical Instruments · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Sands Capital Life Sciences Pulse Fund Ii, L.P.Activist (13D)Apr 23, 2026
- Illumina Innovation Fund Ii, L.P.Activist (13D)Apr 23, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Qiming Corporate Gp Vi, Ltd.10% owner | Apr 20, 2026 | Conversion | 185,163 | — |
| Illumina Innovation Fund Ii Gp, L.L.C.10% owner | Apr 20, 2026 | Conversion | 4.6M | — |
| White Timothy OgdenOfficer — President | Apr 20, 2026 | J | 454,583 | — |
| Chen ShipingOfficer — Chief Operating Officer | Apr 20, 2026 | Conversion | 320,511 | — |
| Luo YulingOfficer — Chief Executive Officer | Apr 20, 2026 | Conversion | 1.4M | — |
| Mcanear Justin J.Officer — Chief Financial Officer | Apr 20, 2026 | Grant | 37,220 | $0.00 |
| Naclerio NicholasDirector | Apr 20, 2026 | Conversion | 4.6M | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.7M | 7.5 | +47.4% |
| Apr 30, 2026 | 1.2M | 1.5 | +100.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recentEvents the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.